Psilocybin Found to Extend Human Cell Lifespan
Breakthrough research that went viral on social media suggests that psilocybin, the psychoactive compound in magic mushrooms, can extend the lifespan of human cells by 51-57%. The same study reportedly showed an 80% improvement in the survival rate of mice. The findings indicate a potential role for psychedelics in anti-aging research beyond their known applications in mental health.
- The preclinical study was a joint effort by researchers at Emory University and Baylor College of Medicine, with the findings published in the scientific journal *npj Aging*. The work was led by senior author Dr. Louise Hecker. - In the laboratory setting, the research team applied psilocin, the active metabolite of psilocybin, to human fetal lung and adult skin cells. The results showed a dose-dependent increase in cellular lifespan, with a 100 micromolar concentration of psilocin extending the lifespan of lung cells by 57% and skin cells by 51%. - The study in mice involved administering monthly doses of psilocybin to aged female mice, equivalent in age to 60-65 year old humans. Over a 10-month period, the survival rate in the psilocybin group was 80%, compared to 50% in the untreated control group. - The potential anti-aging mechanisms identified in the study include a reduction in oxidative stress, preservation of telomere length (the protective caps on the ends of chromosomes), and activation of the SIRT1 protein, a key regulator of cellular aging. - Researchers theorize that psilocybin's impact is systemic because its primary target, the 5-HT2A serotonin receptor, is found on cells throughout the body, not just in the brain. This suggests its effects could extend beyond mental health to influence broader physiological processes related to aging. - This research provides the first experimental evidence for the "psilocybin-telomere hypothesis," which posits a link between the compound's known psychological benefits (like stress reduction) and the biological mechanisms of aging, such as the shortening of telomeres. - The study's authors caution that these are early-stage, preclinical findings and do not justify self-medication for anti-aging purposes. Future human studies are necessary to determine if these results are translatable and to assess potential risks, such as any complex effects on cancer risk from delaying cell senescence.
